SCHEMBL8618030

SCHEMBL8618030

CC1(C)CCC2=C1C(=O)OC2=O

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.33
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
CES2 O00748 1/20 0.32
GMNN O75496 1/20 0.32
TDP2 O95551 1/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
TP53 P04637 1/20 0.32
CYP1A2 P05177 1/20 0.32
GLA P06280 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
MAPT P10636 1/20 0.32
HSPD1 P10809 1/20 0.32
THRB P10828 1/20 0.32
CYP2C9 P11712 1/20 0.32
NQO1 P15559 1/20 0.32
ALOX15 P16050 1/20 0.32
POR P16435 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8621451 0.88 POLB (0.34) KDM4EMEN1CES2ALDH1A1LMNA
SCHEMBL8620334 0.74
SCHEMBL2645904 0.70 ALDH1A1 (0.35) IDO1KDM4EMEN1CES2GMNN
SCHEMBL486948 0.69 KRAS (0.37)
SCHEMBL8619722 0.67 GRIN2D (0.33)
SCHEMBL11833621 0.67 LMNA (0.37) IDO1KDM4EMEN1CES2GMNN
SCHEMBL17122007 0.64 ALDH1A1 (0.46) KDM4EMEN1ALDH1A1MAPTTHRB
SCHEMBL55174 0.64
SCHEMBL11700035 0.64 TSHR (0.41) ALDH1A1LMNATP53ALOX15TDP1
SCHEMBL3030690 0.62 TP53 (0.32) KDM4EMEN1GMNNLMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230278988-A1 THRB RECEPTOR AGONIST COMPOUND AND PREPARATION METHOD AND USE THEREOF TERNS PHARMACEUTICALS, INC. 2023-09-07 US disclosed
US-20230278988-A1 THRB RECEPTOR AGONIST COMPOUND AND PREPARATION METHOD AND USE THEREOF TERNS PHARMACEUTICALS, INC. 2023-09-07 US disclosed
US-11084802-B2 THRβ receptor agonist compound and preparation method and use thereof Terns, Inc. (US) 2021-08-10 US disclosed
CN-113194958-A THR beta receptor agonist compound and preparation method and application thereof 拓臻股份有限公司 2021-07-30 CN disclosed
US-11034676-B2 THRB receptor agonist compound and preparation method and use thereof Terns, Inc. (US) 2021-06-15 US disclosed
US-20200399249-A1 THRB RECEPTOR AGONIST COMPOUND AND PREPARATION METHOD AND USE THEREOF TERNS PHARMACEUTICALS, INC. 2020-12-24 US disclosed
CN-111320609-A THR β receptor agonist compound and preparation method and application thereof 拓臻股份有限公司 2020-06-23 CN disclosed
WO-2020123827-A1 THRΒ RECEPTOR AGONIST COMPOUND AND PREPARATION METHOD AND USE THEREOF Terns, Inc. (US) 2020-06-18 WO disclosed
US-20200190064-A1 THRB RECEPTOR AGONIST COMPOUND AND PREPARATION METHOD AND USE THEREOF TERNS PHARMACEUTICALS, INC. 2020-06-18 US disclosed
EP-0608132-B1 Coating varnish composition and antifouling coating composition HITACHI CHEMICAL CO LTD (JP) 1998-05-20 EP disclosed
US-5646198-A MIXTURE INCLUDES POLYMER, BENZOTRIAZOLE OR TRIAZOLE COMPOUND, AND COMPOUND WITH HYDROPHOBIC AND HYDROPHILIC PARTS; STORAGE STABILITY; MARINE STRUCTURES HITACHI CHEMICAL COMPANY, LTD. (JP) 1997-07-08 US disclosed
US-5439511-A Composition containing polymer obtained by polymerizing unsaturated acid anhydride and another unsaturated compound, specified additive HITACHI CHEMICAL COMPANY, LTD. (JP) 1995-08-08 US disclosed
EP-0659848-A2 Coating composition and antifouling paint Hitachi Chemical Co., Ltd. (JP) 1995-06-28 EP disclosed
EP-0608132-A1 Coating varnish composition and antifouling coating composition HITACHI CHEMICAL CO., LTD. (JP) 1994-07-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200190064-A1 THRB RECEPTOR AGONIST COMPOUND AND PREPARATION METHOD AND USE THEREOF THRB, THRA, TRHR IDO1 2110/4885KDM4E 3160/4885MEN1 997/4885
US-20230278988-A1 THRB RECEPTOR AGONIST COMPOUND AND PREPARATION METHOD AND USE THEREOF THRB, THRA, TRHR IDO1 2110/4885KDM4E 3160/4885MEN1 997/4885
US-11034676-B2 THRB receptor agonist compound and preparation method and use thereof THRB, THRA, TRHR IDO1 2110/4885KDM4E 3160/4885MEN1 997/4885
US-11084802-B2 THRβ receptor agonist compound and preparation method and use thereof THRB, THRA, TRHR IDO1 2178/4885KDM4E 3235/4885MEN1 1201/4885
US-20200399249-A1 THRB RECEPTOR AGONIST COMPOUND AND PREPARATION METHOD AND USE THEREOF THRB, THRA, TRHR IDO1 2110/4885KDM4E 3160/4885MEN1 997/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.